Filter news stories by category:
- UCLH news
- Charity news
-
Research news
- Governors news
- Red Cell Network news
- HTD news
- Reset filter
-
Research news
12 May 2022
UCL has been ranked number one in the UK in medicine, health and the life sciences for the quality of its research.
-
Research news
28 April 2022
People with obesity whose weight and health improve following drug treatment are likely to need the treatment long term, according to a UCLH and UCL study.
-
Research news
07 April 2022
UCLH have been awarded a grant of over half a million pounds to test in clinical practice new technology designed to improve cancer care.
-
Research news
04 April 2022
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
Research news
01 April 2022
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
Research news
28 February 2022
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Research news
20 January 2022
A third ‘booster’ dose of COVID-19 vaccine successfully raises antibody levels that neutralise the Omicron variant, according to laboratory findings from the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre and the Francis Crick Institute.
-
Research news
17 January 2022
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death, according to the results of a trial at UCLH and UCL.
-
Research news
07 January 2022
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
-
Research news
06 December 2021
Six COVID-19 vaccines are safe and boost immunity for people who have had two doses of AstraZeneca or Pfizer-BioNTech, results from the UK-wide COV-BOOST trial show.